can i take tirzepatide more than once a week What to Know Before Starting for Medical Weight Loss How Long Does Tirzepatide Stay?

Key takeaways Zepbound (tirzepatide) can cause stomach pain

Targeted monitoring is advisable for men on long-term GLP-1 therapy, particularly those who have lost significant weight or have specific risk factors

Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program

J.WeiJ.DilleyG.PittmanS

Other GLP-1 Medications Although Ozempic (semaglutide) is a member of the GLP-1 class, its formulation distinguishes it from other medications such as Mounjaro (tripeptidea dual GLP-1 and GIP agonist) and Wegovy (also semaglutide, but at a larger dose) by enabling: Once-weekly dosing Sustained effects on appetite Strong glucose control This makes it suitable for long-term chronic management

49 Phase 3 trials SYNCHRONISE-1 (in people without diabetes) and SYNCHRONISE-2 (in people with diabetes) are ongoing to assess the efficacy and durability of weight loss with 3.6 and 6 mg doses over 76 weeks (clinical trial numbers NCT06066515 and NCT06066528)